ImmunityBio, Inc.
IBRX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$413,645 | -$583,852 | -$416,567 | -$346,790 |
| Dep. & Amort. | $17,554 | $18,512 | $34,542 | $14,300 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $34,432 | $49,163 | $40,179 | $57,181 |
| Change in WC | -$19,422 | $3,977 | -$16,001 | -$15,395 |
| Other Non-Cash | -$10,155 | $145,443 | $20,338 | $16,285 |
| Operating Cash Flow | -$391,236 | -$366,757 | -$337,509 | -$274,419 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$6,888 | -$30,584 | -$78,162 | -$33,563 |
| Net Acquisitions | -$1,000 | $0 | $0 | $0 |
| Inv. Purchases | -$140,218 | -$10,358 | $0 | $0 |
| Inv. Sales/Matur. | $136,607 | $10,472 | $0 | $0 |
| Other Inv. Act. | -$747 | $0 | $105,459 | -$51,323 |
| Investing Cash Flow | -$12,246 | -$30,470 | $27,297 | -$84,886 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $96,892 | $258,623 | $174,067 | $338,500 |
| Stock Issued | $111,357 | $110,103 | $0 | $0 |
| Stock Repurch. | $0 | $0 | -$616 | -$4,064 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $73,381 | $189,615 | $60,162 | $171,007 |
| Financing Cash Flow | $281,630 | $558,341 | $233,613 | $505,443 |
| Forex Effect | -$23 | -$292 | $284 | $48 |
| Net Chg. in Cash | -$121,875 | $160,822 | -$76,315 | $146,186 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $265,787 | $104,965 | $181,280 | $35,094 |
| End Cash | $143,912 | $265,787 | $104,965 | $181,280 |
| Free Cash Flow | -$398,124 | -$397,341 | -$415,671 | -$307,982 |